Bayer Sees Significant, But Smaller, Asundexian Opportunity

BMS Still Confident In Competing Asset Milvexian

 
• By Mandy Jackson
  
Heart activity on monitor in intensive care unit
Bayer sees significant opportunity for asundexian in stroke despite AF miss • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D